Anaemia Management Strategies: Optimising Treatment Using Epoetin Beta (NeoRecormon®)

Publisher： Karger

E-ISSN： 1423-0232|69|2|8-16

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.2, 2005-10, pp. : 8-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimising Anaemia Management with Epoetin Beta

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 12-16

Karger

Access to resources Recommend Favorite

Evolving Treatment Strategies for Anaemia in Cancer: Experience with Epoetin Beta

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

Recombinant human epoetin beta in the treatment of renal anemia

By Del Vecchio Lucia   Cavalli Andrea   Pozzoni Pietro   Locatelli Francesco  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 91-98

Future Medicine

Access to resources Recommend Favorite

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease

By Spinowitz Bruce S.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2507-2513

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia

By Tzekova Valentina   Mihaylov Georgi   Elezovic Ivo   Koytchev Rossen  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1689-1697

Informa Healthcare

Access to resources Recommend Favorite